X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

LEUKEMIA & LYMPHOMA

期刊標題檢索 LEUKEMIA LYMPHO 最新評論: Notification of format change one week after submission on October 9t... (2021-12-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[LEUKEMIA & LYMPHOMA]您好,您是該頁面的第 44526 位訪客。

期刊簡介
期刊名稱LEUKEMIA & LYMPHOMA LEUKEMIA & LYMPHOMA
LetPub Score
6.6
50 ratings
Rate

Reputation
7.6

Influence
5.3

Speed
9.7

期刊簡稱LEUKEMIA LYMPHOMA
ISSN1042-8194
E-ISSN1029-2403
h-index82
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.100.7900.629
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Hematology
Q267 / 137
Category: Medicine
Subcategory: Oncology
Q2201 / 404
Category: Medicine
Subcategory: Cancer Research
Q3149 / 230

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor
官方網站http://informahealthcare.com/journal/lal
在線稿件提交http://mc.manuscriptcentral.com/glal
開放訪問No
出版商Informa Healthcare
主題領域医学
出版國/地區ENGLAND
發行頻率月刊
創刊年1989
每年文章數174每年文章數趨勢
黃金OA百分比16.81%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
HEMATOLOGYSCIEQ353/97
ONCOLOGYSCIEQ3209/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1042-8194%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.8 Month(s)
競爭力 *來自作者的數據: About 66.66%
參考鏈接
相關期刊 【LEUKEMIA & LYMPHOMA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Hematology & OncologyH-index: 60

    CiteScore: 48.10
    BLOODH-index: 426

    CiteScore: 23.60
    LEUKEMIAH-index: 176

    CiteScore: 18.10
    AMERICAN JOURNAL OF HEMATOLOGYH-index: 92

    CiteScore: 15.70
    HAEMATOLOGICAH-index: 125

    CiteScore: 14.10
    BLOOD REVIEWSH-index: 85

    CiteScore: 13.80
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGYH-index: 111

    CiteScore: 11.00
    BRITISH JOURNAL OF HAEMATOLOGYH-index: 172

    CiteScore: 8.60
    SEMINARS IN HEMATOLOGYH-index: 88

    CiteScore: 6.20
    HEMATOLOGICAL ONCOLOGYH-index: 42

    CiteScore: 4.20
    學科內最受檢索的期刊 頁面查看次數
    BLOOD111053
    Journal of Hematology & Oncology101264
    LEUKEMIA58203
    BRITISH JOURNAL OF HAEMATOLOGY50937
    Hematology37485
    ANNALS OF HEMATOLOGY36121
    AMERICAN JOURNAL OF HEMATOLOGY35413
    LEUKEMIA RESEARCH34144
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY32877
    HAEMATOLOGICA27103
  •  

    LEUKEMIA & LYMPHOMA LEUKEMIA & LYMPHOMA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [LEUKEMIA & LYMPHOMA] 的評論撰寫評論
作者: 3030456868


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2021-12-25 10:04:22 評論於
Notification of format change one week after submission on October 9th. Major revisions on November 3rd. Revised version submitted on December 6th. Minor revisions made on the same day as December 16th. Acceptance on December 20th. Not sure when it will be available online. The reviewer is quite diligent and professional.
(1) 讚! | 3030456868

作者: amao


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2018-10-20 17:27:07 評論於
I submitted an article for review. There is no collection fee. I don't know which journals don’t collect fees. The website should list the fees for the authors.

(2) 讚! | amao

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [LEUKEMIA & LYMPHOMA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*